Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2009-04-30
2011-12-06
Aeder, Sean (Department: 1642)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
Reexamination Certificate
active
08071315
ABSTRACT:
Provided herein are compositions and methods of detecting Bcl-B expression in cancer cells to prognose, monitor, or select therapies for cancers such as breast cancer, prostate cancer, lung cancer, or gastric cancer.
REFERENCES:
Tockman et al (Cancer Res., 1992, 52:2711s-2718s).
Bivona et al, PKC regulates a farnesyl-electrostatic switch on K-Ras that promotes its association with Bcl-XL on mitochondria and induces apoptosis, Mol Cell, 21, 481-93 (2006).
Chao et al, Bcl-2 family: regulators of cell death, Annu Rev Immunol, 16, 395-419 (1998).
Chauhan et al, A novel Bcl-2/Bcl-X(L)/Bcl-w inhibitor ABT-737 as therapy in multiple myeloma, Oncogene (2006).
Cheng et al, Conversion of Bcl-2 to a Bax-like death effector by caspases, Science, 278, 1966-8 (1997).
Cheng et al, Mitochondrial factors with dual roles in death and survival, Oncogene, 25, 4697-705 (2006).
Clem et al, Modulation of cell death by Bcl-XL through caspase interaction, Proc Natl Acad Sci USA 95, 554-9 (1998).
Elsaleh, The microsatellite instability phenotype in human colorectal carcinoma: relationship to sex, age, and tumor site, Gastroenterology, 121, 230-1 (2001).
Hanahan et al., The hallmarks of cancer, Cell, 121, 57-70 (2000).
Hans et al, Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray, Blood, 103, 275-82 (2004).
Inohara et al, Diva, a Bcl-2 homologue that binds directly to Apaf-1 and induces BH3-independent cell death, J Biol Chem, 273, 32479-86 (1998).
Ke et al, A novel Bcl-2 family member that differentially binds and regulates Bax and Bak, 276, 12481-4 (2001).
Krajewska et al, Analysis of apoptosis protein expression in early-stage colorectal cancer suggests opportunities for new prognostic biomarkers, Clin Cancer Res, 11, 5451-61 (2005a).
Krajewska et al, Claudin-1 immunohistochemistry for distinguishing malignant from benign epithelial lesions of prostate, Prostate, 67, 907-10 (2007).
Krajewska et al, Elevated expression of inhibitor of apoptosis proteins in prostate cancer, Clin Cancer Res, 9, 4914-25 (2003).
Krajewska et al, Expression of Bcl-2 family member Bid in normal and malignant tissues, Neoplasia, 4, 129-40 (2002).
Krajewska et al, Tumor-associated alterations in caspase-14 expression in epithelial malignancies, Clin Cancer Res, 11, 5462-71 (2005b).
Krajewski et al, Detection of multiple antigens on Western blots, Anal Biochem, 236, 221-8 (1996).
Krajewski et al, Immunohistochemical analysis of Mcl-1 protein in human tissues: differential regulation of Mcl-1 and Bcl-2 protein production suggests a unique role for Mcl-1 in control of programmed cell death in vivo, Am J. Pathol, 146, 1309-19 (1995).
Krajewski et al, Release of caspase-9 from mitochondria during neuronal apoptosis and cerebral ischemia, Proc Natl Acad Sci USA, 96, 5752-7 (1999).
Le Gouill et al, Mcl-1 regulation and its role in multiple myeloma, Cell Cycle, 3, 1259-62 (2004).
Lin et al, Conversion of Bcl-2 from protector to killer by interaction with nuclear orphan receptor TR3/NGFI-B/Nur77, Cell, 116, 527-40 (2004).
Luciano et al, Nur77 converts phenotype of Bcl-B, an antiapoptotic protein expressed in plasma cells and myeloma, Blood, 109, 3849-55 (2007).
Manz et al, Immunological memory stabilizing autoreactivity, Curr Top Microbiol Immunol, 305, 241-57 (2006).
Meinhold-Heerlein et al, Expression and potential role of Fas-associated phosphatase-1 (FAP-1) in ovarian cancer, Amer J Pathol, 158, 1335-44 (2001).
Oancea et al, Apoptosis of multiple myeloma, Int J Hematol, 80, 224-31 (2004).
Radbruch et al, Competence and competition: the challenge of becoming a long-lived plasma cell, Nat Rev Immunol, 6, 741-50 (2006).
Reed et al., Mechanisms of apoptosis (Warner/Lambert Award), Amer J. Pathol, 157, 1415-30 (2000).
Ruifrok et al, Quantification of histochemical staining by color deconvolution, Anal Quant Cytol Histol, 23, 291-9 (2001).
Shapiro-Shelef et al, Blimp-1 is required for maintenance of long-lived plasma cells in the bone marrow, J Exp Med, 202, 1471-6 (2005).
Shapiro-Shelef et al, Regulation of plasma-cell development, Nat Rev Immunol, 5, 230-42 (2005).
Song et al, Boo, a novel negative regulator of cell death, interactst with Apaf-I , EMBO, 18, 167-78 (1998).
Wang et al, Mechanisms of Bcl-2 protein function, Histol Histopathol, 13, 521-30 (1998).
Went et al, Plasma cell quantification in bone marrow by computer-assisted image analysis, Histol Histopathol, 21, 951-6 (2006).
Zhai et al, Comparison of chemical inhibitors of antiapoptotic BcI-2-family proteins, Cell Death Differ, 13, 1419-21 (2006).
Zhang et al, Bc12-K-I 0, a novel anti-apoptotic member of the Bcl-2 family, blocks apoptosis in the mitochondria death pathway but not in the death receptor pathway, Hum Mol Genet, 10, 2329-39 (2001).
Reed et al., Mechanisms of Bcl-2 family protein function and dysfunction in health and disease, Behring Inst Mitt, 97, 72-100 (1996) part 1.
Reed et al., Mechanisms of Bcl-2 family protein function and dysfunction in health and disease, Behring Inst Mitt, 97, 72-100 (1996) part 2.
Krajewska Maryla
Reed John C.
Aeder Sean
Pabst Patent Group LLC
Sanford-Burnham Medical Research Institute
LandOfFree
Detecting Bcl-B expression in cancer and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Detecting Bcl-B expression in cancer and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Detecting Bcl-B expression in cancer and uses thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4266861